<!DOCTYPE html>
<html id=76052c98a2d74f7bad8f10299f9f5b61:98401161 data-origid=98401161 class="anndoc" data-anndoc-version="2.0" lang="" xml:lang="" xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="UTF-8"/>
		<meta name="generator" content="org.rostlab.relna"/>
		<title>76052c98a2d74f7bad8f10299f9f5b61:98401161</title>
	</head>
	<body>
		<article>
			<section data-type="title">
				<h2 id="s1h1">An allosteric drug, o, o'-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B.</h2>
			</section>
			<section data-type="abstract">
				<div class="subsections">
					<h3 id="s2h1">Abstract</h3>
					<p id = "s2s1p1">The efficacy of o, o'-bismyristoyl thiamine disulfide (BMT) was examined in detail against HIV-1 laboratory isolates (HTLV-IIIB, JRFL, and MN), primary isolates (KMT and KMO), and simian immunodeficiency virus (SIVmac251) in vitro. BMT inhibited the replication of HIV-1 in both laboratory and primary isolates in vitro. In addition, BMT exhibited antiviral activity against SIVmac251. Minimizing energy studies of BMT structure reveal that a trans-disulfide of thiamine (holo drug) disulfide (TDS, protodrug) is allosterically transited to the reactive twisted disulfide of BMT (allo drug) by o, o'-bismyristoyl esterification of TDS. BMT inhibits nuclear translocation of both HIV-1 transactivator (TAT) and the cellular transcriptional nuclear factor-KB (NF-kappa B), resulting in the suppression of HIV-1 replication.</p>
				</div>
			</section>
		</article>
	</body>
</html>